| Autor: |
Armstrong, April W., Bissonnette, Robert, Chovatiya, Raj, Bhutani, Tina, Brown, Philip M., Tallman, Anna M., Papp, Kim A. |
| Předmět: |
|
| Zdroj: |
Cutis; Oct2024, Vol. 114 Issue 4, p122-127, 7p |
| Abstrakt: |
The article discusses the outcomes of Phase 3 trials for plaque psoriasis treatment using Tapinarof Cream 1%. The study aimed to achieve treatment targets set by the National Psoriasis Foundation and European guidelines, with positive results showing that a high percentage of patients achieved and exceeded these targets. Tapinarof Cream 1% was found to be an effective topical treatment option for plaque psoriasis, with no limitations on treatment duration or application sites. The study was funded by Dermavant Sciences, Inc. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
